loading
前日終値:
$51.12
開ける:
$51.27
24時間の取引高:
703.90K
Relative Volume:
0.82
時価総額:
$1.11B
収益:
$90.12M
当期純損益:
$-276.06M
株価収益率:
-37.47
EPS:
-1.46
ネットキャッシュフロー:
$-193.47M
1週間 パフォーマンス:
-3.87%
1か月 パフォーマンス:
-5.15%
6か月 パフォーマンス:
+524.43%
1年 パフォーマンス:
+5,370%
1日の値動き範囲:
Value
$51.26
$56.99
1週間の範囲:
Value
$51.04
$59.23
52週間の値動き範囲:
Value
$0.432
$66.92

Nektar Therapeutics Stock (NKTR) Company Profile

Name
名前
Nektar Therapeutics
Name
セクター
Healthcare (1123)
Name
電話
(415) 482-5300
Name
住所
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Name
職員
61
Name
Twitter
@nektarnews
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
NKTR's Discussions on Twitter

NKTR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NKTR
Nektar Therapeutics
54.70 1.04B 90.12M -276.06M -193.47M -1.46
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-26 開始されました Citigroup Buy
2025-06-24 繰り返されました BTIG Research Buy
2025-06-24 繰り返されました H.C. Wainwright Buy
2025-04-11 アップグレード Jefferies Hold → Buy
2025-03-14 アップグレード Oppenheimer Perform → Outperform
2025-01-08 開始されました B. Riley Securities Buy
2024-12-10 開始されました H.C. Wainwright Buy
2024-11-04 開始されました Piper Sandler Overweight
2024-09-30 再開されました BTIG Research Buy
2024-06-28 開始されました Rodman & Renshaw Buy
2023-11-20 再開されました JP Morgan Underweight
2023-11-09 アップグレード TD Cowen Market Perform → Outperform
2023-05-10 アップグレード Jefferies Underperform → Hold
2023-02-24 ダウングレード Jefferies Hold → Underperform
2022-08-08 ダウングレード JP Morgan Neutral → Underweight
2022-05-31 再開されました Jefferies Hold
2022-04-18 ダウングレード Goldman Neutral → Sell
2022-03-15 ダウングレード Cowen Outperform → Market Perform
2022-03-15 ダウングレード Mizuho Buy → Neutral
2022-03-14 ダウングレード BTIG Research Buy → Neutral
2022-03-14 ダウングレード BofA Securities Neutral → Underperform
2022-03-14 ダウングレード Stifel Buy → Hold
2022-03-14 ダウングレード William Blair Outperform → Mkt Perform
2022-03-09 アップグレード Oppenheimer Perform → Outperform
2021-11-08 アップグレード The Benchmark Company Hold → Buy
2021-09-10 開始されました BofA Securities Neutral
2021-06-28 アップグレード Stifel Hold → Buy
2021-05-18 再開されました Goldman Neutral
2021-02-22 ダウングレード The Benchmark Company Buy → Hold
2021-01-06 開始されました Stifel Hold
2020-09-14 開始されました JP Morgan Neutral
2020-06-10 ダウングレード CFRA Hold → Sell
2020-05-12 繰り返されました H.C. Wainwright Neutral
2020-04-22 開始されました The Benchmark Company Buy
2020-03-30 アップグレード Goldman Sell → Neutral
2020-03-04 開始されました Barclays Overweight
2020-02-03 アップグレード Mizuho Neutral → Buy
2019-10-24 開始されました Oppenheimer Perform
2019-10-08 ダウングレード Goldman Buy → Sell
2019-08-09 ダウングレード JP Morgan Overweight → Neutral
2019-08-09 ダウングレード Jefferies Buy → Hold
2019-08-09 ダウングレード Mizuho Buy → Neutral
2019-03-15 開始されました SVB Leerink Mkt Perform
2018-12-13 開始されました Goldman Buy
2018-06-11 ダウングレード H.C. Wainwright Buy → Neutral
2018-06-04 繰り返されました H.C. Wainwright Buy
2018-04-20 開始されました Seaport Global Securities Buy
2018-04-13 再開されました Piper Jaffray Overweight
2018-04-06 繰り返されました Mizuho Buy
2018-04-02 再開されました H.C. Wainwright Buy
すべてを表示

Nektar Therapeutics (NKTR) 最新ニュース

pulisher
Dec 12, 2025

Nektar Therapeutics (NASDAQ:NKTR) Trading Down 5.5%Here's What Happened - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Transformative Advances This Year and Beyond - Dermatology Times

Dec 11, 2025
pulisher
Dec 09, 2025

Can Nektar Therapeutics Stock Recover If Markets Fall? - Trefis

Dec 09, 2025
pulisher
Dec 08, 2025

Here's Why Nektar Therapeutics (NKTR) is a Great Momentum Stock to Buy - sharewise.com

Dec 08, 2025
pulisher
Dec 08, 2025

Nektar Therapeutics $NKTR Shares Sold by 22NW LP - MarketBeat

Dec 08, 2025
pulisher
Dec 07, 2025

Is Nektar Therapeutics (NKTR) Still Undervalued After Its Recent Share Price Rebound? - Yahoo Finance

Dec 07, 2025
pulisher
Dec 05, 2025

Nektar Therapeutics gains amid takeover speculation - MSN

Dec 05, 2025
pulisher
Dec 05, 2025

Nektar Therapeutics (NKTR) Price Target Increased by 14.31% to 109.43 - Nasdaq

Dec 05, 2025
pulisher
Dec 05, 2025

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus

Dec 05, 2025
pulisher
Dec 05, 2025

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Dec 05, 2025
pulisher
Dec 05, 2025

Stonepine Capital Management LLC Makes New Investment in Nektar Therapeutics $NKTR - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 05, 2025
pulisher
Dec 04, 2025

Will Nektar Therapeutics stock maintain dividend yieldOptions Play & Real-Time Volume Trigger Notifications - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Nektar Therapeutics (ITH0) stock stage a strong rebound this quarterPortfolio Performance Summary & Weekly High Return Stock Opportunities - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Nektar Therapeutics stock benefit from green energy trendsTrade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How robust is Nektar Therapeutics (ITH0) stock financial positionAnalyst Upgrade & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How strong dollar benefits Nektar Therapeutics (ITH0) stockTrade Risk Assessment & Long-Term Safe Investment Ideas - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

NKTR SEC FilingsNektar Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025
pulisher
Dec 03, 2025

Will Nektar Therapeutics stock benefit from upcoming earnings reports2025 Top Gainers & Verified Momentum Stock Alerts - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is Nektar Therapeutics stock attractive for ETFs2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Nektar Therapeutics Data from REZOLVE-AD Study Accepted for Late-Breaking Oral Presentation - MSN

Dec 03, 2025
pulisher
Dec 02, 2025

Nektar Therapeutics (NASDAQ:NKTR) Shares Down 7.5%What's Next? - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Colorectal Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | Takeda, Genentech/Seagen, AstraZeneca and Daiichi Sankyo, Merck, Amgen, Daiichi Sankyo Company, Mirati Therapeu - Barchart.com

Dec 02, 2025
pulisher
Dec 02, 2025

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors - The Manila Times

Dec 02, 2025
pulisher
Dec 02, 2025

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors - GlobeNewswire Inc.

Dec 02, 2025
pulisher
Dec 02, 2025

Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $102 - 富途牛牛

Dec 02, 2025
pulisher
Dec 02, 2025

Latex Allergy Market Covering Prime Factors and Competitive - openPR.com

Dec 02, 2025
pulisher
Dec 01, 2025

Wall Street Analysts Believe Nektar (NKTR) Could Rally 64.53%: Here's is How to Trade - Finviz

Dec 01, 2025
pulisher
Nov 29, 2025

Nektar Therapeutics Reveals Promising Phase 2b Trial Results - MSN

Nov 29, 2025
pulisher
Nov 28, 2025

Nektar Therapeutics (NKTR) Stock Forecasts - Yahoo Finance

Nov 28, 2025
pulisher
Nov 27, 2025

Nektar Therapeutics (NASDAQ:NKTR) Shares Gap UpShould You Buy? - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Nektar Therapeutics Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt

Nov 26, 2025
pulisher
Nov 26, 2025

Jefferies Maintains Nektar Therapeutics (NKTR) Buy Recommendation - Nasdaq

Nov 26, 2025
pulisher
Nov 26, 2025

Citigroup Initiates Coverage on NKTR with 'Buy' Rating | NKTR St - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

Jefferies Raises Nektar Therapeutics (NKTR) Price Target to $121 - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

Nektar Therapeutics R (ITH0.MU) Q2 FY2025 earnings call transcript - Yahoo Finance

Nov 26, 2025
pulisher
Nov 26, 2025

Nektar Therapeutics CEO sells $119,795 in shares By Investing.com - Investing.com South Africa

Nov 26, 2025
pulisher
Nov 26, 2025

Citi starts Nektar with Buy, opens ‘positive catalyst watch’ - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

Nektar (NKTR) Receives Buy Rating with Positive Outlook from Cit - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

Citi Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $102 - 富途牛牛

Nov 26, 2025
pulisher
Nov 26, 2025

Portland Topic NEKTAR THERAPEUTICS | News, Weather, Sports, Breaking News - KATU

Nov 26, 2025
pulisher
Nov 26, 2025

Nektar Therapeutics chief R&D officer sells $62,801 in stock By Investing.com - Investing.com Nigeria

Nov 26, 2025
pulisher
Nov 25, 2025

Nektar Therapeutics CLO Wilson sells $34,196 in shares By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

Nektar Therapeutics Announces Pricing of $100 Million Public Offering (PR Newswire) - Aktiellt

Nov 25, 2025
pulisher
Nov 25, 2025

Nektar Therapeutics chief R&D officer sells $62,801 in stock - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

Nektar Therapeutics CLO Wilson sells $34,196 in shares - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

VP Zalevsky Acquires 1,509 Of Nektar Therapeutics [NKTR] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

VP Wilson Surrenders 630 Of Nektar Therapeutics [NKTR] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

CEO Robin Files To Sell 2,207 Of Nektar Therapeutics [NKTR] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

VP Wilson Files To Sell 630 Of Nektar Therapeutics [NKTR] - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

VP Zalevsky Files To Sell 1,157 Of Nektar Therapeutics [NKTR] - TradingView

Nov 25, 2025

Nektar Therapeutics (NKTR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Nektar Therapeutics (NKTR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Wilson Mark Andrew
Chief Legal Officer
Nov 25 '25
Sale
54.28
630
34,196
21,585
ROBIN HOWARD W
President & CEO
Nov 25 '25
Sale
54.28
2,207
119,796
54,245
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
大文字化:     |  ボリューム (24 時間):